Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Hybrid Gene Mapping Approach Yields Reference Quality Results

By LabMedica International staff writers
Posted on 15 Jul 2015
A team of genomics researchers from the USA and Europe have developed a new approach for describing nearly complete genomes by combining high-throughput DNA sequencing with genome mapping techniques.

Conventional next-generation sequencing (NGS) techniques are able to accurately detect certain types of variation, such as single nucleotide variants and small insertions or deletions, but miss many large or complex forms of genomic variation that are associated with human disease. More...


To overcome the inherent limitations of existing NGS methods, investigators at the Icahn School of Medicine at Mount Sinai (New York, NY, USA), several other American research institutions, and the European Molecular Biology Laboratory (Hamburg, Germany) combined two single molecule approaches. These were the long read sequencing method from Pacific Biosciences (Menlo Park, CA, USA) and Nanochannel Array and Irys reader technology from BioNano Genomics (San Diego, CA, USA). Pacific Biosciences sequencing enables reads exceeding 10 kilobases in length, which can directly resolve and phase complex forms of variation. The NanoChannel Array method confines and linearizes DNA molecules up to megabases in length to provide high-resolution genome maps.

The two techniques were combined into a hybrid approach that was used to analyze the NA12878 diploid genome, a well-sequenced specimen that is included in the 1000 Genomes project and is often used for benchmarking new techniques.

The investigators reported in the June 29, 2015, online edition of the journal Nature Methods that the hybrid assembly method markedly improved upon the contiguity observed from traditional shotgun sequencing approaches. They were able to identify complex structural variants (SVs) missed by other high-throughput approaches. In addition, they phased both single-nucleotide variants and SVs, generating haplotypes with over 99% consistency with previous trio-based studies.

“We created a high-throughput strategy that builds highly contiguous de novo genomes without the need for complex jumping libraries or targeted approaches. This strategy, in some cases, automatically resolved complete arms of chromosomes,” said senior author Dr. Ali Bashir, assistant professor of genetics and genomics at the Icahn School of Medicine. “While we focused this study on a human genome, the method can be applied to any new genome, including those with high genomic complexity, such as plants, that have been extremely challenging to study.”

“The study revealed an unprecedented view of genomic complexity, in many cases identifying regions overlooked by conventional sequencing or further refining previously known genetic variant classes,” said contributing author Dr. Jan Korbel, group leader at the European Molecular Biology Laboratory.

Related Links:

Icahn School of Medicine at Mount Sinai
European Molecular Biology Laboratory
BioNano Genomics 



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.